Image 01
Mircera Injection, Solution
Product Images NDC 59353-402
39 FDA label images from Vifor (international) Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Mircera (NDC 59353-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vifor (international) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
An instructional diagram showing the parts of an injection device for Mircera (Methoxy polyethylene glycol-epoetin beta). Labeled components include the plunger rod, release clips, expiry date area, tear off label, device body, plastic needle guard, rubber tip cap, needle, cap, and needle shield.*
Image 03
An instructional illustration showing four medical disposal and cleaning items labeled as an adhesive bandage, cleansing alcohol swab, sterile cotton ball or gauze, and a sharps container for safe disposal of needles and used syringes.*
Image 04
An instructional illustration depicting a hand placing a rectangular box into a refrigerator. This image likely relates to storage instructions for the medication Mircera (methoxy polyethylene glycol-epoetin beta) injection solution.*
Image 05
Mircera injection solution packaged in a prefilled syringe within a clear plastic tray. The syringe is designed for intravenous administration. No specific strength or volume is visible on the syringe or packaging in this image. Labeler shown as Vifor (International) Inc.*
Image 06
An instructional illustration depicting hand washing under running water from a faucet. One hand is being rinsed while the other supports it, demonstrating proper technique to ensure cleanliness.*
Image 07
An instructional illustration showing a hand removing a prefilled syringe from its tray packaging by lifting it upward after peeling back a protective film covering the tray. The tray is molded to securely hold the syringe in place.*
Image 08
An instructional illustration showing a hand holding a prefilled syringe labeled with an expiration date. The diagram emphasizes visually checking the syringe's label before use, highlighting the expiration information area on the syringe barrel.*
Image 09
An instructional illustration showing how to remove the cap from a prefilled syringe. One hand holds the syringe barrel while the other hand twists and pulls the protective cap off the needle end, preparing the syringe for injection use.*
Image 10
An instructional illustration showing two hands performing a step in preparing an injection. One hand is holding the cap of a syringe, and the other is rotating or pulling the syringe plunger and needle assembly, indicating how to remove the cap from the syringe before use.*
Image 11
Illustration showing how to attach a needle to a syringe held in one hand, with the other hand holding the needle. An arrow indicates the direction to connect the needle to the syringe barrel.*
Image 12
An instructional anatomical diagram showing acceptable injection sites on the human body from both front and back views. Highlighted areas include the abdomen above the waist, the outer thighs, and the upper arms, indicating appropriate locations for intravenous injections.*
Image 13
An illustration showing a hand wiping a vertical surface with a cloth or wipe, suggesting a cleaning or preparation action.*
Image 14
An instructional illustration showing two hands preparing an injection. The left hand holds a syringe aligned horizontally, and the right hand holds the cap removed from the syringe needle, indicated by an arrow pointing from the needle to the cap. This likely demonstrates the step of removing the needle cap before injection.*
Image 15
An instructional illustration showing two hands handling a syringe. One hand holds the syringe upright while the other hand is positioned to pull or adjust a part near the needle end, likely representing a step in preparing an injection.*
Image 16
An instructional illustration showing a hand holding a syringe with the plunger being pulled upward, indicating the action of drawing or preparing injection solution. No specific branding or labeling is visible on the syringe in the image.*
Image 17
An instructional illustration showing a hand holding a syringe at the injection site on a patient's arm or leg. The syringe is positioned for an intravenous injection, demonstrated by a downward arrow indicating the direction of needle insertion.*
Image 18
An instructional illustration showing a hand holding an injection device vertically above the skin surface, with an arrow pointing downward, indicating the device is about to be pressed or inserted into the skin.*
Image 19
Illustration showing a hand removing the cap or cover from a syringe with a needle, with an upward arrow indicating the direction to pull. This instructional diagram is likely related to the preparation of Mircera (methoxy polyethylene glycol-epoetin beta) injection solution for intravenous use.*
Image 20
An illustration showing a hand holding and preparing a prefilled syringe for injection, indicating the plunger being pulled back. This instructional diagram likely demonstrates how to use an injection device properly.*
Image 21
An instructional diagram showing the assembly or use of a prefilled syringe with a protective cap removed, highlighting internal components such as the plunger and spring mechanism, likely demonstrating preparation for injection.*
Image 22
An instructional line drawing showing a person seated with one hand placed on their thigh above the knee, likely demonstrating a position or area related to an injection site or medical procedure involving the leg.*
Image 23
An instructional illustration showing a hand cleaning a medical connector or device with a cloth or wipe. The image demonstrates proper hygiene or preparation technique, likely related to injection or intravenous procedures.*
Image 24
An instructional illustration showing one hand holding a syringe with the plunger pulled back and the other hand holding a needle cap, indicating the step to remove the needle cap before use. The image emphasizes proper handling of the syringe and needle prior to injection.*
Image 25
An instructional illustration showing two hands preparing a syringe, with one hand holding the syringe and the other pulling a cap or seal from the needle area. The image demonstrates an aspect of syringe preparation or injection technique.*
Image 26
An instructional illustration showing a hand holding a syringe filled with solution, with an upward-pointing arrow indicating the direction to pull or lift the syringe plunger. The syringe is depicted with a needle on top and a filled barrel. No text or additional labeling is visible.*
Image 27
Instructional diagram showing a hand holding a syringe, with the needle positioned above a black rectangular device, indicating the syringe should be inserted or aligned downward into the device. No text is visible in the image.*
Image 28
An instructional illustration showing a hand holding a syringe injecting a solution into a medical device or tubing, indicating preparation or administration of an injection. No specific product branding or labeling is visible.*
Image 29
An instructional black-and-white illustration showing a hand holding a prefilled syringe labeled Mircera (methoxy polyethylene glycol-epoetin beta) injection. The image depicts the syringe with its plunger being pulled back, with an arrow indicating the direction of plunger movement, suggesting preparation steps for intravenous administration.*
Image 30
An instructional diagram showing a hand holding a prefilled syringe with a protective cap or cover around the needle area, illustrating how to handle or prepare the syringe for injection.*
Mircera 01
Mircera 30 mcg/0.3 mL prefilled syringe label showing the brand name, generic name methoxy polyethylene glycol-epoetin beta, and dosage strength. The label indicates it is a sterile solution for intravenous or subcutaneous use, single-dose only with a 27 gauge needle. The labeler is Vifor Pharma, and storage instructions include keeping refrigerated. The label includes a message for pharmacists about an enclosed Medication Guide.*
Mircera 02
Mircera 50 mcg / 0.3 mL injection solution label shows the product name and active ingredient (methoxy polyethylene glycol-epoetin beta). It is a sterile solution for intravenous or subcutaneous use only. Packaging includes a single-dose prefilled syringe with a 27 gauge needle. Labeler is Vifor Pharma. Directions to keep refrigerated and a pharmacist medication guide warning are also visible.*
Mircera 03
Mircera 75 mcg / 0.3 mL injection solution label for intravenous or subcutaneous use. The label shows the proprietary name Mircera with the generic name methoxy polyethylene glycol-epoetin beta. It is a single-dose prefilled syringe with a 27 gauge needle, requiring refrigeration. Labeler is Vifor Pharma.*
Mircera 04
Mircera 100 mcg / 0.3 mL injection solution label for intravenous or subcutaneous use. The label shows methoxy polyethylene glycol-epoetin beta as the active ingredient, with a single-dose prefilled syringe and 27 gauge needle. The labeler is Vifor Pharma. Instructions include refrigerate storage and discarding unused portions.*
Mircera 05
Label for Mircera injection solution, containing methoxy polyethylene glycol-epoetin beta at 120 mcg/0.3 mL strength. The label indicates single-dose use with a prefilled syringe and 27 gauge needle, for intravenous or subcutaneous administration. It also includes storage instructions to keep refrigerated and is labeled by Vifor Pharma.*
Mircera 06
Mircera 150 mcg/0.3 mL injection solution label showing methoxy polyethylene glycol-epoetin beta as the active ingredient. The label indicates it is for intravenous or subcutaneous use, provided in a single-dose prefilled syringe with a 27 gauge needle. The product is distributed by Vifor Pharma and requires refrigeration.*
Mircera 07
Mircera 200 mcg / 0.3 mL injection solution label showing methoxy polyethylene glycol-epoetin beta as the active ingredient. The label indicates it is for intravenous or subcutaneous use only, packaged in a single-dose prefilled syringe with a 27 gauge needle. The product is labeled by Vifor Pharma and requires refrigeration.*
Mircera 08
Label for Mircera injection, solution containing methoxy polyethylene glycol-epoetin beta at 250 mcg per 0.3 mL. The label indicates it is a sterile solution for intravenous or subcutaneous use, supplied as a single-dose prefilled syringe with a 27 gauge needle. The labeler is Vifor Pharma. Storage instructions include Keep Refrigerated, and it states Rx only.*
Mircera 09
Mircera 360 mcg / 0.6 mL injection, solution label for methoxy polyethylene glycol-epoetin beta. The label indicates sterile solution for intravenous or subcutaneous use only. It is a single-dose prefilled syringe with a 27 gauge needle. Labeler: Vifor Pharma. The label includes instructions to keep refrigerated and a pharmacist medication guide notice.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
